(secondQuint)Serranator Alto Post Market Clinical Follow Up (PMCF) Study.

 Single Arm, multi-center, device registry study capturing de-identified data on a minimum of 100 subjects with peripheral artery disease (PAD) and/or dysfunctional native or synthetic arteriovenous dialysis fistulae.

 The study will capture acute angiographic data.

.

 Serranator Alto Post Market Clinical Follow Up (PMCF) Study@highlight

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator(R) Alto in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario.

